Table 1.
SNP | Gene | Function/Pathway | Phenotype | Sample/cancer | Number of patients | Author/year | OR | 95% CI | P value |
---|---|---|---|---|---|---|---|---|---|
rs28419191 | STING1 | Inflammation/immune system | Mucositis | Blood DNA/HNC | 1780 | Schack et al./2022. [57] | 2.27 | 1.70–3.05 | 4.4E-08 |
rs10875554 | STING1 | Inflammation/immune system | Mucositis | Blood DNA/HNC | 1780 | Schack et al./2022. [57] | 2.25 | 1.68–3.01 | 5.1E-08 |
rs1131769 | DNAJC18 | Chaperone molecules protecting other cellular proteins | Mucositis | Blood DNA/HNC | 1780 | Schack et al./2022. [57] | 2.21 | 1.66–2.95 | 7.6E-08 |
rs1265081 | CCHCR1 | keratinocyte proliferation or differentiation/EGFR | Mucositis | Blood DNA/HNC | 500 | Li et al./2021. [58] | 1.41 | 1.08–1.86 | 0.012 |
rs3135001 | HLA-DQB1 | MHC class II, immune system | Mucositis | Blood DNA/HNC | 500 | Li et al./2021. [58] | 0.53 | 0.35–0.79 | 0.002 |
rs117157809 | TNKS | Telomere capping and maintenance and telomerase activity | Mucositis | Blood DNA/NPC | 1467 | Yang et al./2020. [59] | 3.72 | 2.10–6.57 | 6.33E − 6 |
rs1799964 | TNF-α | Proinflammatory cytokines | Mucositis | Blood DNA/HNC | 62 | Mlak et al./2020. [60] |
6.61 | 2.14–20.40 | 0.001 |
rs1799782 | XRCC1 | DNA repair | Oral mucositis | Blood DNA/laryngeal cancer | 150 | Raturi et al./2020. [61] | 6.9 | 1.4–34.7 | 0.01 |
rs1799782 | XRCC1 | DNA repair | Dermatitis | Blood DNA/laryngeal cancer | 150 | Raturi et al./2020. [61] | 2.0 | 1.0–3.6 | 0.02 |
rs10898880 | ATG16L2 | Autophagy | Mucositis | Blood DNA/NPC | 468 | Yang et al./2019. [62] | 1.56 | 1.19–2.04 | 0.001 |
rs10514231 | ATG10 | Autophagy | Mucositis | Blood DNA/NPC | 468 | Yang et al./2019. [62] | 1.95 | 1.31–2.9 | 0.001 |
rs25487 | XRCC1 | DNA repair | Mucositis | Blood DNA/OPC | 179 | Gupta et al./2019. [63] | 2.629 | 1.136–6.087 | 0.024 |
rs4149570 | TNFRSF1A | TNF-α Proinflammatory | Mucositis | Blood DNA/HNC | 58 | Brzozowska et al./2018. [64] | 5.625 | 1.584–19.975 | 0.008 |
rs1629816 | GHRL | Modifier of proinflammatory cytokine activity | Mucositis | Blood DNA/HNC | 65 | Brzozowska et al./2018. [65] | 5.92 | 1.58–22.22 | 0.008 |
rs4855883 | APEH | Proteasome degradation | Mucositis | Blood DNA/HNC | 62 | Brzozowska et al./2018. [66] | 0.23 | 0.07–0.77 | 0.0166 |
rs9344 | CCND1 | Cell cycle. | Mucositis | Blood DNA/NPC | 154 | Guo et al./2017. [67] | 0.08 | 0.01–0.66 | 0.019 |
NF-κB signaling | |||||||||
rs1800541 | EDN1 | Angiogenesis-related genes | Mucositis | Blood DNA/NPC | 180 | Ma et al./2017. [68] | 2.020 | 1.039–3.928 | 0.038 |
rs11081899 | ZNF24 | DNA replication, and DNA damage response, NF-κB activation, tumor progression and angiogenesis | Mucositis | Blood DNA/NPC | 33 | Le et al./2017. [69] | 14.631 | 2.61–105.46 | 1.2E10 − 4 |
rs375557 | GSK3β | Wnt/β-catenin pathway | Mucositis and dermatitis | Blood DNA/NPC | 188 | Yu et al./2016. [70] | 2.34 | 1.05–5.21 | 0.033 |
rs454886 | APC | Wnt/β-catenin pathway | Mucositis and dermatitis | Blood DNA/NPC | 188 | Yu et al./2016. [70] | 1.57 | 1.01–2.43 | 0.045 |
rs1805794 | NBN | DNA damage response, DNA repair | Mucositis | Blood DNA/HNC | 183 | Venkatesh et al./2014. [71] | 3.750 | 1.201–11.70 | 0.023 |
rs132788 | KU70 | DNA repair | Mucositis | Blood DNA/NPC | 120 | Ren et al./2014. [72] | 3.041 | 1.257–7.360 | 0.014 |
rs25487 | XRCC1 | DNA repair | Mucositis and dermatitis | Blood DNA/NPC | 114 | Li et al./2013. [73] | 2.65 | 1.04–6.73 | 0.037 |
rs25487 | XRCC1 | DNA repair | Mucositis | Blood DNA/HNC | 101 | Pratesi et al./2011. [74] | 4.02 | 1.16–13.90 | 0.025 |
rs2067079 | GAS5 | Glucocorticoid receptors. Apoptosis and cell cycle. | Oral mucositis | Blood LncRNA/NPC | 238 | Guo et al./2017. [75] | 3.031 | 1.014–9.055 | 0.047 |
rs6790 | GAS5 | Glucocorticoid receptors. Apoptosis and cell cycle. | Dermatitis | Blood LncRNA/NPC | 238 | Guo et al./2017. [75] | 0.026 | 0.001–0.464 | 0.013 |
OR: Odds ratio, CI: Confidence Interval.